Clinical Trials Logo

Clinical Trial Summary

The overall rationale for this investigation is to evaluate the clinical performance potential for Mepilex Border Post-Op Ag in the ability to minimize the risk of skin related post-operative wound complications such as blistering, maceration and redness at the incision and surrounding skin.


Clinical Trial Description

This was a descriptive, open, prospective, non-controlled clinical investigation conducted on 21 enrolled subjects at one site in the United states of America (USA).

The target subjects were male or female, 18 years and older, undergoing elective primary hip or knee arthroplasty with a possibility to participate in a follow-up visit 7 days after surgery. The primary purpose was to investigate if there was any skin damage under the dressing from operation day to last visit. Performance of the dressing as well as comfort, conformability, acceptability and pain at dressing removal was also followed-up until post-op day 7. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03016078
Study type Interventional
Source Molnlycke Health Care AB
Contact
Status Completed
Phase N/A
Start date February 1, 2017
Completion date April 7, 2017

See also
  Status Clinical Trial Phase
Completed NCT02906033 - The Effect of A New Perioperative Practice Model on Patient, Nursing And Organisational Outcomes N/A
Active, not recruiting NCT06203756 - Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty N/A
Completed NCT03272178 - Impact of Component Design and Fixation in Total Knee Arthroplasty
Active, not recruiting NCT04167163 - Abaloparatide Before Total Knee Arthroplasty Phase 4
Recruiting NCT06095401 - Swelling Management After Knee Replacement N/A